"Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients." Neurology - Neuroimmunology Neuroinflammation 7.6 (2020): e882. Web. 12 Aug. 2022.